Kamiya Hideki, Himeno Tatsuhito, Watarai Atsuko, Baba Masayuki, Nishimura Rimei, Tajima Naoko, Nakamura Jiro
Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195 Japan.
Department of Innovative Diabetes Therapy, Aichi Medical University School of Medicine, Nagakute, Japan.
Diabetol Int. 2024 Jan 12;15(1):19-27. doi: 10.1007/s13340-023-00678-2. eCollection 2024 Jan.
AIM/INTRODUCTION: This study aims to investigate the prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy (DSPN) in patients with type 2 diabetes registered in the Japan Diabetes Complication and its Prevention Prospective (JDCP) study.
In the study, 6338 patients with diabetes who had been treated by diabetes specialists were registered in 2007-2009. Of these, patients with type 2 diabetes who could be evaluated for DSPN were analyzed using test, chi-square test, and logistic regression analyses. DSPN was diagnosed using the Simple Diagnostic Criteria for Diabetic Polyneuropathy proposed by the Diabetic Neuropathy Study Group in Japan.
Of the total participants, 5451 patients (mean age 61.4 years old and duration of diabetes 10.8 years) were analyzed. Based on the criteria, 35.8% of patients were diagnosed with DSPN. The prevalence of sensory symptoms was 25.8%. The following factors increased risk for DSPN: age [odds ratio (OR) 1.57, 95% confidence intervals (CI) 1.42-1.73], duration of diabetes (OR 1.32, 95% CI 1.21-1.43), body mass index (OR 1.19, 95% CI 1.09-1.30), systolic blood pressure (OR 1.06, 95% CI 1.01-1.10), hemoglobin A1c (OR 1.15, 95% CI 1.09-1.22), biguanides (OR 1.22, 95% CI 1.06-1.39), and insulin therapy (OR 1.59, 95% CI 1.36-1.84). The following factors decreased risk for DSPN: total cholesterol (OR 0.98, 95% CI 0.96-1.00) and exercise therapy (OR 0.85, 95% CI 0.73-0.98).
The baseline survey clarified the prevalence and characteristics of DSPN in Japanese patients with type 2 diabetes. The survey also revealed the risk factors of DSPN.
目的/引言:本研究旨在调查在日本糖尿病并发症及其预防前瞻性(JDCP)研究中登记的2型糖尿病患者糖尿病对称性感觉运动性多发性神经病变(DSPN)的患病率和特征。
在本研究中,2007 - 2009年登记了6338例由糖尿病专科医生治疗的糖尿病患者。其中,对可评估DSPN的2型糖尿病患者进行检验、卡方检验和逻辑回归分析。DSPN采用日本糖尿病神经病变研究组提出的糖尿病多发性神经病变简易诊断标准进行诊断。
共分析了5451例参与者(平均年龄61.4岁,糖尿病病程10.8年)。根据该标准,35.8%的患者被诊断为DSPN。感觉症状的患病率为25.8%。以下因素会增加DSPN的风险:年龄[比值比(OR)1.57,95%置信区间(CI)1.42 - 1.73]、糖尿病病程(OR 1.32,95% CI 1.21 - 1.43)、体重指数(OR 1.19,95% CI 1.09 - 1.30)、收缩压(OR 1.06,95% CI 1.01 - 1.10)、糖化血红蛋白(OR 1.15,95% CI 1.09 - 1.22)、双胍类药物(OR 1.22,95% CI 1.06 - 1.39)和胰岛素治疗(OR 1.59,95% CI 1.36 - 1.84)。以下因素会降低DSPN的风险:总胆固醇(OR 0.98,95% CI 0.96 - 1.00)和运动疗法(OR 0.85,95% CI 0.73 - 0.98)。
基线调查明确了日本2型糖尿病患者DSPN的患病率和特征。该调查还揭示了DSPN的危险因素。